LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
LIPELLA PHARMACEUTICALS INC.
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.27K
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Lipella Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Jun 12, 2026 | Jul 15, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 31, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2026 | Feb 4, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 20, 2025 | Oct 21, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 3, 2025 | Oct 9, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 18, 2025 | Sep 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2025 | Jun 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 20, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2025 | Jun 16, 2025 | SEC EDGAR |
| Current report | 8-K | May 16, 2025 | May 16, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 9, 2025 | Apr 9, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2025 | Apr 7, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2025 | Mar 18, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2025 | Mar 11, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2025 | Feb 24, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2025 | Feb 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 10, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 31, 2024 | Jan 6, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 30, 2024 | Dec 30, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 27, 2024 | Dec 27, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 20, 2024 | Dec 20, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 5, 2024 | Dec 10, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 6, 2024 | Dec 6, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 6, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 1, 2024 | Nov 1, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 18, 2024 | Oct 18, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2024 | Sep 11, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 23, 2024 | Aug 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 10, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 6, 2024 | SEC EDGAR |